Report Overview

Governments and NGOs’ increasing focus on reducing the number of unintended pregnancies and related health complications, and increasing knowledge of people about the benefits of contraceptives could drive India Contraceptives (Drugs and Devices) Market at a steady growth rate during the forecast period between 2022 and 2028.

Governments and NGOs’ increasing focus on reducing the number of unintended pregnancies and related health complications, and increasing knowledge of people about the benefits of contraceptives could drive India Contraceptives (Drugs and Devices) Market at a steady growth rate during the forecast period between 2022 and 2028.

India Contraceptives Market (Drugs and Devices)

During the forecast period between 2022 and 2028, India contraceptives (drugs & devices) market is expected to grow at a CAGR of over 8.5%. An increasing focus on controlling population growth and high HIV incidence is expected to drive the growth of India contraceptives (drugs & devices) market. Various awareness programs by government and NGOs to promote the use of contraceptives are also aiding the growth. In addition, increased knowledge about the use of condoms to prevent the spread of Sexually Transmitted Infections (STIs), particularly HIV, is boosting the contraceptive drugs and devices market growth in India. Contraceptive devices lead the contraceptives market in India. The segment is predicted to maintain its dominance through 2028 due to the ease of use, the ability to have contraception for an extended period, the lack of side effects, and the ability of devices to prevent STDs.

Contraceptive devices of various forms are used in the country, with condoms being the most popular among consumers in India. The Government of India and non-profit organizations have been striving to increase awareness about contraception and its benefits to prevent unplanned pregnancies and sexually transmitted infections (STIs). For example, under the government-sponsored Family Planning Programme, IUDs, oral contraceptive pills, condoms, and emergency contraceptive pills are provided at a reduced or no cost to low-income people. Furthermore, Vasalgel and Reversible Inhibition of Sperm Under Guidance (RISUG), innovative injectables for males, is expected to benefit the country's contraception business over the next five years.

India Contraceptives Market (Drugs and Devices) - Industry Trends and Forecasts

The requirement of minimizing unwanted pregnancies and its repercussions is one of the primary drivers of the expansion of contraceptives market in India. The urge to prevent unplanned births, particularly among adolescent women, is one of the key drivers of this need. Non-contraceptive medical advantages, such as treatment for extended monthly bleeding, menstrual cramps, and acne, are only considered by about half of the women. This could be one of the key factors driving market expansion.

The Indian contraceptive device market is expected to be dominated by condoms. A condom is a sheath-shaped barrier device intended to prevent pregnancy or STIs during sexual contact. Both men’s and women’s condoms are available. Women whose partners use male condoms have a 2% annual pregnancy rate when used properly. The risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS is reduced when condoms are used. Condoms also protect users against genital herpes, human papillomavirus (HPV), and syphilis. Other factors that contribute to the growth of the contraceptive devices industry include the increased focus on reduce the high prevalence of STDs and population growth.

India Contraceptives Market (Drugs and Devices)

Growth Drivers

Increased awareness about contraceptive drugs and devices

A major factor for the increasing demand for contraceptive devices and drugs is to prevent increasing number of occurrences of unwanted or mistimed pregnancies in various regions of the world. According to a research study conducted by the World Health Organisation in 36 countries, promiscuous women who wanted to delay pregnancy did not use contraception, resulting in one in every four pregnancies being unwanted. The research also discovered that 9.9% of the women in the sample had unwanted pregnancies. Main causes driving the increase in the number of cases of unwanted births include lack of education, combined with a lack of understanding about contraception in economies, as well as restricted access to devices and pharmaceuticals. Government, on the other hand, is playing a significant role in raising public awareness of these products and educating people about good family planning through programs and campaigns. This, in turn, could increase the demand for contraceptive drugs and devices in India during the forecast period.

Restraints

Social stigma and side effects could limit demand for contraceptives

Although there is an increasing awareness about contraceptives in urban areas of India, there is still a significant gap in the knowledge about contraceptives in rural India due to lack of education, low literacy rate among females, and social stigma associated with the use of contraceptives. Consequently, lack of education and awareness and taboos could affect the growth of contraceptives market in rural areas of India.

The health risks involved with taking tablets and using other devices may limit demand, which is a negative factor for market growth during the forecast period. Oral tablets have a variety of negative effects, including nausea, migraines, and severe abdominal pain. All these considerations make women hesitant to use them. This, in turn, may limit the demand for contraceptive drugs in India.

Impact of COVID-19 on India Contraceptives Market (Drugs and Devices)

COVID-19 pandemic dominated 2020, infecting about two million people. On one hand, diagnostics, personal protective equipment, and crucial medical supplies saw unprecedented demand, while on the other hand, medical procedures fell by 50% to 60%, depending on the market. Over the forecast period, the paper examines the impact of a pandemic and recovery scenarios for Contraceptive Drugs and Devices. As businesses restructure their resources to operate within the pandemic's constraints, the research outlines three market recovery scenarios: Low Growth, Reference Case, and High Growth. Supply chain interruptions, consumer confidence, economic impact, and general industry recovery considerations are all considered in these cases.

Segment Coverage

India Contraceptives (Drugs & Devices) Market

India contraceptives (drugs & devices) market is majorly segmented by drugs, devices, distribution channels.

India Contraceptives (Drugs & Devices) Market – By Drugs

Based on drugs, India contraceptives (drugs & devices) market is further divided into Oral drugs, Injectables, and Patches. The Oral drugs segment is categorized into combined contraceptives and Progesterone Only Pills. Among the drugs, Oral drugs is expected to maintain its dominance in India contraceptives market during the forecast period.

India Contraceptives (Drugs & Devices) Market – By Devices

India contraceptives (drugs & devices) market by devices has two major sub-segments: Product and Technology. The product category is further divided into Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms & Sponges, Vaginal Rings, Intrauterine Devices, Sub-dermal Implants, and Others. Among contraceptive products, the male contraceptive devices category, including male condoms, is expected to continue its dominance during the forecast period. The technology segment has two major sub-segments: Hormonal Contraceptives and Barrier Contraceptives.

India Contraceptives (Drugs & Devices) Market – By Distribution Channel

By distribution channel, India contraceptives (drugs & devices) market is segmented into Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO, and Others. Among them, the retail pharmacy segment holds the highest market share in India contraceptives market by distribution channel. Major factor for the retail pharmacy’s dominance is the over the counter (OTC) availability of contraceptive drugs and devices in retail pharmacies across India. The online channel, however, is expected to grow at the fastest rate during the forecast period due to the increasing popularity of e-commerce and deepening penetration of mobile internet and smartphones.

Competitive Landscape

There are various firms in India contraceptive drugs and devices market. Prominent players in the market include Piramal Enterprises Ltd., Famy Care, Cipla, Hindustan Latex Ltd., Contech Devices, SMB Corp., Pregna, Agile Therapeutics, Janssen Global Services, LLC, CooperSurgical, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Amneal Pharmaceuticals Inc., Bayer AG, Pfizer Inc., Reckitt Benckiser Group plc, and Mankind Pharma. Companies are concentrating on expanding their product portfolios, diversifying their business operations, lowering costs, increasing customer contentment, and improving contraceptive drugs and devices reliability in India. In terms of market share, a few significant firms now dominate the market. In addition, large corporations are aggressively pursuing acquisitions and joint ventures with other companies to expand their market reach in the country.

Recent Developments

• In January 2021 - the Durex-supported Condom Alliance joined with the MASH Project Foundation to increase awareness about the importance of sexual health and safe sex.

• In September 2021 - Reckitt Benckiser-owned Durex launched a new campaign to sell its newly developed extra–thin flavored condoms in India.

Scope of the Report

By Drugs

• • • • Product

        • Oral

          • Combined Contraceptives

          • Progesterone Only Pills

        • Injectable

        • Patches

By Devices

• • • • Product

        • Male Contraceptive Devices

        • Female Contraceptive Devices

        • Female Condoms, Diaphragms & Sponges

        • Vaginal Rings

        • Intrauterine Devices

        • Sub-dermal Implants

        • Others

      • Technology

        • Hormonal Contraceptives

        • Barrier Contraceptives

    • By Distribution Channel

      • Hospital Pharmacy

      • Retail Pharmacy

      • Clinics

      • Online Channels

      • Public Channel & NGO

      • Others